Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors

Journal of Nuclear Medicine

Volumn 39, Issue 9, 1998, Pages 1600-1604

  Sumiya, Hisashi ^a   Taki, Junichi ^b   Tsuchiya, Hiroyuki ^b   Nonomura, Akitaka ^b   Miyauchi, Tsutomu ^b   Tonami, Norihisa ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Bone tumor; Chemotherapy; Soft tissue tumor; Thallium 201

Indexed keywords

CAFFEINE; CISPLATIN; DOXORUBICIN; THALLIUM 201;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PREDICTION; PRIORITY JOURNAL; SCINTIGRAPHY; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SOFT TISSUE NEOPLASMS; THALLIUM RADIOISOTOPES; TREATMENT OUTCOME;

EID: 0031660363     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tsuchiya H, Tomita K, Minematsu K, Mori Y, Asada N, Kitano S. Limb salvage using distraction osteogenesis. A classification of the technique. J Bone Joint Surg Br 1997;79:403-411.
2. Eliber FR, Morton DL, Eckardt J, Grant T, Weisenburger T. Limb salvage for skeletal and soft tissue sarcomas. Cancer 1984;53:2579-2584.
3. Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Cancer 1983;51:402-407.
4. McCall D, Zimmer LJ, Katz AM. Kinetics of thallium exchange in cultured rat myocardial cells. Circ Res 1985;56:370-376.
5. Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990;31:567-572.
6. Tomita K, Tsuchiya H. Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 1989;80:83-88.
7. Tsuchiya H, Tomita K, Yasutake H, et al. Intraarterial cisplatin and caffeine with/without doxorubicin for musculoskeletal high-grade spindle cell sarcoma. Oncol Rep 1994;1:27-36.
8. Tsuchiya H, Tomita K. Intra-arterial chemotherapy combined with caffeine for bone and soft-tissue sarcomas. Jpn J Cancer Clin 1995;41:1156-1164.
9. Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop 1993; 293:302-306.
10. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy. J Bone Joint Surg Am 1993;75:526-531.
11. Terui S, Terauchi T, Abe H, et al. On clinical usefulness of Tl-201 scintigraphy for the management of malignant soft tissue tumors. Ann Nucl Med 1994;8:55-64.
12. 201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors. Kaku Igaku 1994;31:1477-1494.
13. Lin J, Leung WT, Ho SK, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995;22:553-555.
14. Ohtomo K, Terui S, Yokoyama R, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med 1996;37:1444-1448.
15. Taki J, Sumiya H, Tsuchiya H, Tomita K, Nonomura A, Tonami N. Evaluating benign and malignant bone and soft tissue lesions with technetium-99m-MIBI scintigraphy. J Nucl Med 1997;38:501-506.
16. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988;6:329-337.
17. Hudson M, Jaffe MR, Jaffe N, et al. Pediatric osteosarcoma: therapeutic strategies, results and prognostic factors derived from a 10-year experience. J Clin Oncol 1990;8:1988-1997.
18. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5-15.
19. Hoekstra OS, Ossenkoppele GJ, Golding R, et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18 fluorodeoxyglucose scintigraphy. J Nucl Med 1993;34:1706-1710.
20. Yeh SDJ, Rosen G, Caparros B, Benua RS. Semiquantitative gallium scintigraphy in patients with osteogenic sarcoma. Clin Nucl Med 1984;9:175-183.